Related Experiment Video

Updated: Feb 25, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study

Paola Mozzoni1, Luca Ampollini2, Matteo Goldoni3

  • 1Molecular Genetics, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Disease Markers
|August 1, 2017
PubMed
Abstract

Insights

Diagnostic and prognostic biomarkers for asbestos-related diseases are crucial. This study found decreased levels of specific microRNAs (miRNAs) in patients with malignant pleural mesothelioma (MPM) and asbestosis (ASB), with miRNA-16 showing prognostic value in MPM.

Area of Science:

  • Biomarker discovery
  • Molecular diagnostics
  • Asbestos-related diseases

Background:

  • Early diagnosis and prognosis of asbestos-related diseases are critical for patient survival.
  • Understanding molecular mechanisms is key to disease development and progression.

Purpose of the Study:

  • To identify microRNA (miRNA) patterns as diagnostic biomarkers for malignant pleural mesothelioma (MPM) and asbestosis (ASB).
  • To identify miRNA patterns as prognostic biomarkers for MPM patients.

Main Methods:

  • Quantified miRNA-16, miRNA-17, miRNA-126, and miRNA-486 in plasma and tissue samples.
  • Compared miRNA expression in patients with MPM and ASB against controls with noncancerous pulmonary diseases.

Main Results:

  • All tested miRNAs were significantly lower in MPM and ASB patients compared to controls.
  • miRNA-16, miRNA-17, and miRNA-486 showed significant correlations in MPM patients (plasma and tissue).
  • miRNA-16 (plasma and tissue) and miRNA-486 (tissue) expression correlated positively with cumulative survival in MPM patients.

Conclusions:

  • Decreased miRNA levels in MPM and ASB patients support circulating miRNAs as potential biomarkers for asbestos-related diseases.
  • miRNA-16 is directly related to MPM patient prognosis, indicating its potential as a prognostic marker.

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.3K
Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR08:56

Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR

Published on: June 27, 2017

8.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K